Franziska S. Schulze

Luebeck, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.

Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.

Journal: Frontiers in immunology

Published: January 16, 2018

Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.

Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.

Journal: Frontiers in immunology

Published: October 17, 2017

Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases.

Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases.

Journal: Frontiers in immunology

Published: May 03, 2017

Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human Disease.

Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human Disease.

Journal: The Journal of investigative dermatology

Published: January 17, 2017

Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.

Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.

Journal: JAMA dermatology

Published: November 10, 2016

The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.

The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.

Journal: The Journal of investigative dermatology

Published: August 11, 2016

IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.

IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.

Journal: Expert review of clinical immunology

Published: November 21, 2015

Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 14, 2015

Malignancies in pemphigus and pemphigoid diseases.

Malignancies in pemphigus and pemphigoid diseases.

Journal: The Journal of investigative dermatology

Published: January 07, 2015

Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid.

Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid.

Journal: The American journal of pathology

Published: February 20, 2014

Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.

Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.

Journal: European journal of dermatology : EJD

Published: December 17, 2013

GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.

GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 17, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026